Asia-Pacific to see fastest growth in SMRT sequencing through 2030

Thanks to rising public and private investment in genomics.

The Asia-Pacific region is expected to be the fastest-growing market for single-molecule real-time (SMRT) sequencing technology until 2030, with the global market projected to reach $5.32b over the forecast period.

The region’s expansion is supported by rising public and private investment in genomics, the expansion of genome centres, and advanced hospital labs, according to a MarketsandMarkets report.

“Growth is also being lifted by stronger use of long-read sequencing in rare disease testing, complex variant resolution, cancer research, and translational studies,” it said.

Moreover, a rise in national and multi-institutional programmes is scaling sequencing adoption.

“These institutes depend on SMRT for de novo genome assembly, structural variant mapping, repeat expansion studies, haplotype phasing, and full-length transcript sequencing,” the report added.